Advance biomarker candidates with greater confidence

Biomarker programs require researchers to identify biologically relevant signals and then confirm them across increasingly large and complex patient populations. Many workflows generate deep discovery insights or robust quantitative measurements, but struggle to provide both in a scalable and reproducible manner. This can slow progression from biomarker discovery to validation and reduce confidence in critical development decisions.

Scale from discovery to validation on a single platform

Generate the deep biological insight needed to discover potential biomarkers and the reproducible quantitative data required to evaluate them across larger validation cohorts.

Confident biomarker decisions start with deeper coverage

The ZenoTOF 8600 system combines sensitive molecular characterization with reproducible quantitative performance, helping researchers identify potential biomarkers, prioritize candidates, and evaluate them across expanding study populations using a consistent analytical approach.

Built for cohort-scale studies

Generate robust and reproducible datasets across hundreds to thousands of samples, helping research teams confidently assess biomarker performance as studies progress from discovery to validation.

Deliver reproducible quantitative results across hundreds to thousands of samples, helping researchers confidently advance the most promising biomarker candidates.